Stephens & Co. Maintains Overweight on Steris, Raises Price Target to $250
Portfolio Pulse from Benzinga Newsdesk
Stephens & Co. analyst Jacob Johnson maintains an Overweight rating on Steris (NYSE:STE) and raises the price target from $240 to $250.
July 17, 2023 | 3:57 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Stephens & Co. maintains an Overweight rating on Steris and raises the price target from $240 to $250, which could lead to a positive market reaction.
The raised price target by Stephens & Co. indicates a positive outlook for Steris. This could lead to increased investor confidence and potentially a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100